Future Trends in the Global Constipation Laxative Market: 2024 Size and Growth Drivers

Global constipation laxative market size is expected to reach $8.89 Bn by 2028 at a rate of 6.2%, segmented as by drug type, bulk-forming laxatives

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Future Trends in the Global Constipation Laxative Market: 2024 Size and Growth Drivers

Overview and Scope
Constipation laxatives are medications or substances used to stimulate bowel movements or soften stool to relieve constipation. They include various types, such as stool softeners and stimulant laxatives. These treatments work by different mechanisms to ease the passage of stool through the intestines.

Sizing and Forecast
The constipation laxative market size has grown strongly in recent years. It will grow from $6.60 billion in 2023 to $7.00 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%.  The growth in the historic period can be attributed to the increasing number of elderly individuals, lack of physical activity, greater awareness about digestive health, easy access to laxatives, and rising incidence of gastrointestinal diseases.

The constipation laxative market size is expected to see strong growth in the next few years. It will grow to $8.89 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.  The growth in the forecast period can be attributed to increased recommendations from doctors and pharmacists, regulatory changes impacting drug approval, growth in the functional foods market, increased availability and distribution of laxatives, and the rise of e-commerce platforms. Major trends in the forecast period include advancements in pharmaceuticals, improved manufacturing processes, ongoing research into gastrointestinal health, product innovations, and the development of combination formulations.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Segmentation & Regional Insights
The constipation laxative market covered in this report is segmented –

1) By Drug Type: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxative, Other Drugs
2) By Route Of Administration: Oral, Rectal
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

North America was the largest region in the constipation laxative market in 2023. The regions covered in the constipation laxative market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16021&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of constipation is expected to propel the growth of the constipation laxative market going forward. Constipation is a symptom characterized by infrequent bowel movements, typically fewer than three times a week, and difficulty passing hard, dry stools. The prevalence of constipation has been rising due to various factors, including changes in dietary habits, sedentary lifestyles, inadequate fluid intake, and certain medical conditions or medications. Constipation laxatives are used to alleviate constipation by stimulating bowel movements or softening stools. They help restore regularity and ease discomfort when dietary and lifestyle changes are insufficient. For instance, in January 2024, according to the survey of 1,139 participants conducted in Saudi Arabia on individuals aged 18 and above by Cureus, a US-based peer-reviewed journal, a total of 811 participants, comprising 71.2% of the total, reported either current or past experiences with constipation. Therefore, the increasing prevalence of constipation is driving the growth of the constipation laxative market.

Key Industry Players
Major companies operating in the constipation laxative market are  Procter & Gamble Corporation, Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, AstraZeneca PLC, Abott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmBH, Reckitt Benckiser Group plc, Fresenius Kabi AG, Daiichi Sankya Company Limited, Eisai Co. Ltd, Sun Pharmaceutical Ltd, Purdue Pharma LP, Shionogi & Co. Ltd, Dr. Reddy's Laboratories Ltd., Cipla Limited, Mallinckrodt Pharmaceuticals, Ironwood Pharmaceuticals, Beutlich Pharmaceuticals LLC

The constipation laxative market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company  
Twitter: https://twitter.com/tbrc_info  
Facebook: https://www.facebook.com/TheBusinessResearchCompany  
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  
Blog: https://blog.tbrc.info/  
Healthcare Blog: https://healthcareresearchreports.com/  
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model